fusion	source	treatment	cancerType	doid	level	direction
EML4_ALK	CIViC	Crizotinib	Lung Cancer	X	A	Responsive
PCM1_JAK2	OncoKB	Ruxolitinib	Leukemia	X	B	Responsive